Investing.com – Canada stocks were higher after the close on Wednesday, as gains in the IT, Healthcare and Energy sectors led shares higher. At the close in Toronto, the S&P/TSX...
Investing.com – Canada stocks were lower after the close on Thursday, as losses in the Healthcare, Real Estate and Materials sectors led shares lower. At the close in Toronto, the...
By Svea Herbst-Bayliss (Reuters) - Billionaire investor William Ackman's activist hedge fund Pershing Square (NYSE:SQ) Capital Management LP is opposing United Technologies...
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) reported mixed results for the third quarter of 2019. The company lowered its annual revenue guidance. Consequently, shares are down in...
Bausch Health Companies Inc.’s (NYSE:BHC) earnings and sales beat estimates in the third quarter of 2019. Moreover, the company raised its annual sales guidance.The...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Technical Indicators||Strong Buy||Strong Buy||Strong Buy||Strong Buy||Strong Buy|
|Summary||Strong Buy||Strong Buy||Strong Buy||Strong Buy||Strong Buy|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Doji Star Bearish||5H||Current|
|Deliberation Bearish||1W||1||Nov 03, 2019|
|Doji Star Bearish||1W||1||Nov 03, 2019|
|Falling Three Methods||1M||3||Aug 19|
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.Read More
|National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States)||$500||Start Trading|
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
|Securities Investor Protection Corporation (United States)||$0||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.